References
1. Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot, and mouth disease in China, 2008–12: an epidemiological study. The Lancet Infectious Diseases. 2014;14(4):308-18.
2. Zhou X, Zhu Q, Xia W, He F, Hu M, Ni X, et al. Molecular epidemiology of an outbreak of hand, foot, and mouth disease associated with subgenotype C4a of enterovirus A71 in Nanchang, China in 2014. J Med Virol. 2015;87(12):2154-8.
3. Zhu P, Ji W, Li D, Li Z, Chen Y, Dai B, et al. Current status of hand-foot-and-mouth disease. J Biomed Sci. 2023;30(1):15.
4. Palacios G, Oberste MS. Enteroviruses as agents of emerging infectious diseases. J Neurovirol. 2005;11(5):424-33.
5. Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, Chen YJ, et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 1999;29(1):184-90.
6. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778-90.
7. Feng X, Guan W, Guo Y, Yu H, Zhang X, Cheng R, et al. A novel recombinant lineage’s contribution to the outbreak of coxsackievirus A6-associated hand, foot and mouth disease in Shanghai, China, 2012-2013. Sci Rep. 2015;5:11700.
8. Kamau E, Nguyen D, Celma C, Blomqvist S, Horby P, Simmonds P, et al. Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006-2017. Emerg Infect Dis. 2021;27(9):2261-8.
9. Liu H, Zhang M, Feng C, Cong S, Xu D, Sun H, et al. Characterization of Coxsackievirus A6 Strains Isolated From Children With Hand, Foot, and Mouth Disease. Front Cell Infect Microbiol. 2021;11:700191.
10. Tomba Ngangas S, Bisseux M, Jugie G, Lambert C, Cohen R, Werner A, et al. Coxsackievirus A6 Recombinant Subclades D3/A and D3/H Were Predominant in Hand-Foot-And-Mouth Disease Outbreaks in the Paediatric Population, France, 2010-2018. Viruses. 2022;14(5).
11. Kanbayashi D, Kaida A, Yamamoto SP, Hirai Y, Kubo H, Fujimori R, et al. Impact of Coxsackievirus A6 emergence on hand, foot, and mouth disease epidemic in Osaka City, Japan. J Med Virol. 2017;89(12):2116-21.
12. He F, Rui J, Deng Z, Zhang Y, Qian K, Zhu C, et al. Surveillance, Epidemiology and Impact of EV-A71 Vaccination on Hand, Foot, and Mouth Disease in Nanchang, China, 2010-2019. Front Microbiol. 2021;12:811553.
13. Zhao Z, Zheng C, Qi H, Chen Y, Ward MP, Liu F, et al. Impact of the coronavirus disease 2019 interventions on the incidence of hand, foot, and mouth disease in mainland China. Lancet Reg Health West Pac. 2022;20:100362.
14. Yang Y, Yu M. Response to global public health emergency: Overview and lessons from Chinese experience against COVID-19. J Glob Health. 2023;13:03016.
15. Li Y, Chang Z, Wu P, Liao Q, Liu F, Zheng Y, et al. Emerging Enteroviruses Causing Hand, Foot and Mouth Disease, China, 2010-2016. Emerg Infect Dis. 2018;24(10):1902-6.
16. Ge S, Yan Q, He S, Zhuang S, Niu J, Xia N. Specific primer amplification of the VP1 region directed by 5’ UTR sequence analysis: enterovirus testing and identification in clinical samples from hand-foot-and-mouth disease patients. J Virol Methods. 2013;193(2):463-9.
17. Ji T, Han T, Tan X, Zhu S, Yan D, Yang Q, et al. Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017. Biosafety and Health. 2019;1(1):32-40.
18. Gao LD, Hu SX, Zhang H, Luo KW, Liu YZ, Xu QH, et al. Correlation analysis of EV71 detection and case severity in hand, foot, and mouth disease in the Hunan Province of China. PLoS One. 2014;9(6):e100003.
19. Chen JF, Zhang RS, Ou XH, Chen FM, Sun BC. The role of enterovirus 71 and coxsackievirus A strains in a large outbreak of hand, foot, and mouth disease in 2012 in Changsha, China. Int J Infect Dis. 2014;28:17-25.
20. Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370(9):829-37.
21. Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson PCD, Thorburn F, et al. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S A. 2019;116(52):27142-50.
22. Staring J, van den Hengel LG, Raaben M, Blomen VA, Carette JE, Brummelkamp TR. KREMEN1 Is a Host Entry Receptor for a Major Group of Enteroviruses. Cell Host Microbe. 2018;23(5):636-43 e5.
23. Tang Q, Xu Z, Zhang F, Cai Y, Chen Y, Lu B, et al. Identification of a novel binding inhibitor that blocks the interaction between hSCARB2 and VP1 of enterovirus 71. Cell Insight. 2022;1(2).
24. Head JR, Collender PA, Lewnard JA, Skaff NK, Li L, Cheng Q, et al. Early evidence of inactivated enterovirus 71 vaccine impact against hand, foot, and mouth disease in a major center of ongoing transmission in China, 2011-2018: a longitudinal surveillance study. Clin Infect Dis. 2019.
25. Song Y, Zhang Y, Ji T, Gu X, Yang Q, Zhu S, et al. Persistent circulation of Coxsackievirus A6 of genotype D3 in mainland of China between 2008 and 2015. Sci Rep. 2017;7(1):5491.
26. Wang J, Teng Z, Cui X, Li C, Pan H, Zheng Y, et al. Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012-2016. Emerg Microbes Infect. 2018;7(1):8.